Cited 27 time in
Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Do Hun | - |
| dc.contributor.author | Kim, Tae Han | - |
| dc.contributor.author | Lee, Seung Ho | - |
| dc.contributor.author | Lee, Ai Young | - |
| dc.date.accessioned | 2024-08-08T03:31:08Z | - |
| dc.date.available | 2024-08-08T03:31:08Z | - |
| dc.date.issued | 2017-12 | - |
| dc.identifier.issn | 1013-9087 | - |
| dc.identifier.issn | 2005-3894 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/17113 | - |
| dc.description.abstract | Background: Palmar hyperhidrosis is a common disorder of excessive sweating. A number of studies have demonstrated the effectiveness of iontophoresis in the treatment of palmar hyperhidrosis. However, controlled clinical studies on iontophoresis for palmar hyperhidrosis have been limited. Objective: To determine the efficacy and safety of iontophoresis in the treatment of palmar hyperhidrosis with a randomized, sham-controlled, single-blind, and parallel-designed study. Methods: Twenty nine patients with significant palmar hyperhidrosis were enrolled in this study. They received active iontophoresis treatment (group A) or sham treatment (group B). lontophoresis was performed 20 minutes each time, five times per week, for 2 weeks. Its efficacy was assessed with starch-iodine test, mean sweat secretion rate, and hyperhidrosis disease severity scale. Results: Twenty-seven of the 29 patients completed the 2-week treatment. After completion of 10 times of treatment, results of the starch-iodine test showed clinical improvement in 92.9% of patients in group A and 38.5% of patients in group B (p=0.001). The mean sweat secretion rate was reduced by 91.8% of patients in group A and by 39.1 % of patients in group B (p<0.001). Improvement in quality of life was reported by 78.6% of patients in group A and by 30.8% of patients in group B (p=0.028). In group A, one case of localized adverse event was noted, although no adverse event was encountered in group B. Conclusion: Tap water iontophoresis could be used as an effective and safe treatment modality for palmar hyperhidrosis. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN DERMATOLOGICAL ASSOC | - |
| dc.title | Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5021/ad.2017.29.6.728 | - |
| dc.identifier.scopusid | 2-s2.0-85035339572 | - |
| dc.identifier.wosid | 000433991700007 | - |
| dc.identifier.bibliographicCitation | ANNALS OF DERMATOLOGY, v.29, no.6, pp 728 - 734 | - |
| dc.citation.title | ANNALS OF DERMATOLOGY | - |
| dc.citation.volume | 29 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 728 | - |
| dc.citation.endPage | 734 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002285032 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Dermatology | - |
| dc.relation.journalWebOfScienceCategory | Dermatology | - |
| dc.subject.keywordPlus | PALMOPLANTAR HYPERHIDROSIS | - |
| dc.subject.keywordPlus | ALTERNATING-CURRENT | - |
| dc.subject.keywordAuthor | Hyperhidrosis | - |
| dc.subject.keywordAuthor | lontophoresis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
